Wound healing and its impairment in the diabetic foot (Q36314100)

13 August 2017

1 reference

title

Wound healing and its impairment in the diabetic foot (English)

1 reference

13 August 2017

1 reference

Vincent Falanga

1

1 reference

PubMed ID

16291068

13 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

13 August 2017

1 reference

13 August 2017

366

1 reference

13 August 2017

1736-1743

1 reference

13 August 2017

9498

1 reference

Parallels between tissue repair and embryo morphogenesis

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Wound healing--aiming for perfect skin regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Cutaneous wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Identification of cDNAs associated with late dedifferentiation in adult newt forelimb regeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

1 reference

7 January 2021

Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

The chronic wound: impaired healing and solutions in the context of wound bed preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Cellular and molecular facets of keratinocyte reepithelization during wound healing.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Alpha3beta1 integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: a novel mechanism of integrin-mediated MMP gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Integrin alpha3beta1 directs the stabilization of a polarized lamellipodium in epithelial cells through activation of Rac1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Integrins control motile strategy through a Rho-cofilin pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Significance of N-methyl-D-aspartate (NMDA) receptor-mediated signaling in human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Matrix metalloproteinases: their function in tissue repair

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

1 reference

7 January 2021

Wound healing and treatments for people with diabetic foot ulcers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

The International Consensus and practical guidelines on the management and prevention of the diabetic foot

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Microcirculation of the diabetic foot

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

A review of the mechanisms implicated in the pathogenesis of the diabetic foot

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Modulating poly (ADP-ribose) polymerase activity: potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

The distribution of peripheral vascular disease in a Dutch Caucasian population: comparison of type II diabetic and non-diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Chronology and determinants of tissue repair in diabetic lower-extremity ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Clinical practice. Neuropathic diabetic foot ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Protocol for treatment of diabetic foot ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Vertical forces acting on the feet of diabetic patients with neuropathic ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

The effect of diabetes mellitus on chemotactic and bactericidal activity of human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Wound healing: biologic features and approaches to maximize healing trajectories

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Oxygen: from the benefits of inducing VEGF expression to managing the risk of hyperbaric stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Classifications for wound bed preparation and stimulation of chronic wounds

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

The "trap" hypothesis of venous ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Pathogenetic implications of hyaluronan-induced modification of vascular smooth muscle cell fibrinolysis in diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Pressure-induced cellular senescence: a mechanism linking venous hypertension to venous ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

An analysis of replicative senescence in dermal fibroblasts derived from chronic leg wounds predicts that telomerase therapy would fail to reverse their disease-specific cellular and proteolytic phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Fibroblasts from chronic wounds show altered TGF‐β‐signaling and decreased TGF‐β Type II Receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Comparison of keratinocyte proliferation in diabetic and non-diabetic inflamed gingiva

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Hyperbaric oxygen therapy for chronic wounds

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Wound dressings in diabetic foot disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Growth factors in the treatment of diabetic foot ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Gene transfer in tissue repair: status, challenges and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Off-loading the diabetic foot wound: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Wounding of bioengineered skin: cellular and molecular aspects after injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Survival of Apligraf in acute human wounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

The longevity of a bilayered skin substitute after application to venous ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Adult stem cell lines in regenerative medicine and reconstructive surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

Treatment of Chronic Wounds With Bone Marrow–Derived Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967700-8

7 January 2021

10.1016/S0140-6736(05)67700-8

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16291068